BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37849765)

  • 1. Case Report: Fatal cytomegalovirus pneumonia after CAR-T cell therapy in the long-term follow-up.
    Cheng J; Huang J; Cao W; Huang L; Mao X; Chen L; Zhou J; Wang N
    Front Immunol; 2023; 14():1226148. PubMed ID: 37849765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus (CMV) Reactivation and CMV-Specific Cell-Mediated Immunity After Chimeric Antigen Receptor T-Cell Therapy.
    Kampouri E; Ibrahimi SS; Xie H; Wong ER; Hecht JB; Sekhon MK; Vo A; Stevens-Ayers TL; Green DJ; Gauthier J; Maloney DG; Perez A; Jerome KR; Leisenring WM; Boeckh MJ; Hill JA
    Clin Infect Dis; 2024 Apr; 78(4):1022-1032. PubMed ID: 37975819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Cytomegalovirus Replication in Patients with Aggressive B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy.
    Márquez-Algaba E; Iacoboni G; Pernas B; Esperalba J; Los Arcos I; Navarro V; Monforte A; Beas F; Albasanz-Puig A; Carpio C; Barba P; Ruiz-Camps I
    Transplant Cell Ther; 2022 Dec; 28(12):851.e1-851.e8. PubMed ID: 36221995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections after chimeric antigen receptor (CAR)-T-cell therapy for hematologic malignancies.
    Kampouri E; Little JS; Rejeski K; Manuel O; Hammond SP; Hill JA
    Transpl Infect Dis; 2023 Nov; 25 Suppl 1():e14157. PubMed ID: 37787373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
    Madduri D; Parekh S; Campbell TB; Neumann F; Petrocca F; Jagannath S
    J Med Case Rep; 2021 Feb; 15(1):90. PubMed ID: 33608053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lmphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
    Ma RZ; He Y; Yang DL; Wei JL; Pang AM; Jiang EL; Wang JX; Han MZ; Zhang RL; Feng SZ
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):383-389. PubMed ID: 34218580
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma.
    Zu C; Xu Y; Wang Y; Zhang M; Zhao H; Fang X; Huang H; Hu Y
    Curr Oncol; 2022 Jan; 29(2):490-496. PubMed ID: 35200544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of CD19 and CD22 CAR-T cell therapy in relapsed B-cell acute lymphoblastic leukemia after allogeneic transplantation.
    Liu S; Deng B; Yin Z; Lin Y; An L; Liu D; Pan J; Yu X; Chen B; Wu T; Chang AH; Tong C
    Am J Hematol; 2021 Jun; 96(6):671-679. PubMed ID: 33725422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomegalovirus pneumonia treated with ganciclovir and intravenous CMV-hyperimmune globulin: case report].
    Kitagawa K; Tashiro T; Shigeno H; Nakayama T; Kikuchi H; Nasu M
    Kansenshogaku Zasshi; 1992 Oct; 66(10):1488-91. PubMed ID: 1338089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and toxicity for CD22/CD19 chimeric antigen receptor T-cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma involving the gastrointestinal tract.
    Zeng C; Cheng J; Li T; Huang J; Li C; Jiang L; Wang J; Chen L; Mao X; Zhu L; Lou Y; Zhou J; Zhou X
    Cytotherapy; 2020 Mar; 22(3):166-171. PubMed ID: 32063474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of CD19 Chimeric Antigen Receptors T Cells in the Treatment of Relapsed Patients with B Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation].
    Chen HR; Zhang Y; Chen P; Liu XD; Huang Q; Zhang J; Li HM; Liu B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1040-1045. PubMed ID: 31418354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell Therapy.
    Chen W; Ma Y; Shen Z; Chen H; Ma R; Yan D; Shi M; Wang X; Song X; Sun C; Cao J; Cheng H; Zhu F; Sun H; Li D; Li Z; Zheng J; Xu K; Sang W
    Front Immunol; 2021; 12():755549. PubMed ID: 34777367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy.
    Li W; Ding L; Shi W; Wan X; Yang X; Yang J; Wang T; Song L; Wang X; Ma Y; Luo C; Tang J; Gu L; Chen J; Lu J; Tang Y; Li B
    J Transl Med; 2023 Mar; 21(1):213. PubMed ID: 36949487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report.
    Chen HH; Kuo CY; Ho CL; Chen YC
    Medicine (Baltimore); 2023 Oct; 102(41):e35432. PubMed ID: 37832125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD19 CAR-T Cells With Membrane-Bound IL-15 for B-Cell Acute Lymphoblastic Leukemia After Failure of CD19 and CD22 CAR-T Cells: Case Report.
    Sun Y; Su Y; Wang Y; Liu N; Li Y; Chen J; Qiao Z; Niu J; Hu J; Zhang B; Ning H; Hu L
    Front Immunol; 2021; 12():728962. PubMed ID: 34691036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review.
    Du J; Zhang Y
    J Cancer Res Clin Oncol; 2020 Jun; 146(6):1575-1582. PubMed ID: 32222815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia.
    Papazian L; Fraisse A; Garbe L; Zandotti C; Thomas P; Saux P; Pierrin G; Gouin F
    Anesthesiology; 1996 Feb; 84(2):280-7. PubMed ID: 8602657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in immunodeficiency-related genes may increase the risk of infection after CAR-T-cell therapy: a report of two cases.
    Wang D; He L; Li C; Xu M; Yu Q; Almeida VDF; Que Y; Xu Y; Xiao Y; Li C
    BMC Infect Dis; 2023 Feb; 23(1):109. PubMed ID: 36814216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus pneumonia in a patient with T-lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: A case report.
    Li Q; Wang K; Guo W; Lu M
    Medicine (Baltimore); 2019 Jan; 98(4):e14221. PubMed ID: 30681598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.